Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -11.602% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] Br.COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1
[b] CN(CC(O)CN1CCOCC1)S(=O)(=O)[O-].[Na+]
[c] CCC(C(=O)NCc1cccnc1)n1nc(C)n2c(cc3occc32)c1=O
[d] CCC1CN(C(=O)N2CCC(C(=O)NCCc3ccccc3)CC2)c2ccccc2O1
[e] CSCCC(NC(=O)c1ccccc1)C(=O)OCC(=O)c1ccc[nH]1
Answer: e. CSCCC(NC(=O)c1ccccc1)C(=O)OCC(=O)c1ccc[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCCC(NC(=O)c1ccccc1)C(=O)OCC(=O)c1ccc[nH]1
CSCCC(NC(=O)c1ccccc1)C(=O)OCC(=O)c1ccc[nH]1
[2-oxo-2-(1H-pyrrol-2-yl)ethyl] 2-benzamido-4-methylsulfanylbutanoate